Lundbeck, Teva settle Cipralex patent fight; Watson wins FDA nod for Pulmicort copy;

@FiercePharma: Watson got FDA nod for its Pulmicort knockoff. Patent fight with AstraZeneca pending, so no launch yet. Report | Follow @FiercePharma

> Lundbeck said it had settled with Teva Pharmaceutical Industries ($TEVA) in a patent fight over its antidepressant Cipralex. Report

> Watson Pharmaceuticals ($WPI) won FDA approval for its version of the $1.1 billion AstraZeneca asthma drug Pulmicort, but a patent fight between the two companies is still pending. Report

> Optimer Pharmaceuticals ($OPTR) got a boost from Centers for Medicare & Medicaid Services, which bumped up reimbursement for hospital use of its C. difficile treatment Dificid. Report

> Alliance Pharma snapped up three antimalarial brands from AstraZeneca ($AZN) for £4.2 million ($6.5 million), plus up to £1 million ($1.5 million), depending upon future sales. Report

> The U.K. government plans to change National Health Service rules to allow patient data to be used by the pharma industry in research. Report

Medical Device News

@FierceMedDev: The $3.8B deal is done. Hologic wrapped up its bid to acquire Gen-Probe. Release | Follow @FierceMedDev

 @MarkHFierce: Regulators in Singapore lowered import fees for blood pressure monitors and hearing aids. More | Follow @MarkHFierce

 @DamianFierce: Covidien has opened up its $45M R&D shop in Shanghai. News | Follow @DamianFierce

> CareFusion hit with Class I recall of infusion pump component. News

> Becton, Dickinson trims expectations after Q3 loss. More

Biotech News

 @FierceBiotech: RIP: After long illness, Genta finally opts to liquidate. News | Follow @FierceBiotech

 @JohnCFierce: Bristol's bad, awful, not very good day. Pensions exec charged with insider trading, via Bloomberg. And it's still early. More | Follow @JohnCFierce

 @RyanMFierce: A Google search for scientific experts? AstraZeneca adopts search engine for scientists from David Steinberg's Knode. Article | Follow @RyanMFierce

> R&D shift sees new jobs in China as Western ops are restructured. Article

> Report: Bristol exec nabbed on insider trading charge. Item

> Halozyme blitzed as FDA rejects Baxter drug, halts combo trial. Story

> Analyst reads last rites after heart failure scuttles Bristol hep C study. News

Vaccines News

> Old whooping cough vax more effective than new. News

> AstraZeneca wins Fluenz contract in U.K. Article

> Survey: U.S. females fail to finish Merck and GSK HPV shots. More

> NIH awards $5M for heroin addiction, AIDS vaccine. News

> Alnylam gets $3.2M milestone from GSK for vax tech. Story

Pharma Manufacturing News 

> Hospira CEO Ball says it's getting 'gators' under control. Report

> Rexam eyes factory growth, despite lagging healthcare sales. More

> CMC nabs Xoma's Bay Area plant. Article

And Finally ... Would patients risk side effects in the hopes of preventing a heart attack? Depends which side effects. Report